Bleselumab (ASKP 1240) is a humanised monoclonal antibody targeting CD40, characterised by high affinity (Kd = 0.24 nM), blocking the interaction between CD40 and its ligand CD40L and inhibiting immune responses, and is indicated for the prevention of organ transplant rejection.
Purity:
95.00%
CAS Number:
[1453067-91-8]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted